Paul Hartmann AG | Income Statement

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,794
1,862
1,941
1,986
2,059
2,119
Cost of Goods Sold (COGS) incl. D&A
1,279
1,300
1,376
1,380
1,468
1,518
Gross Income
515
562
565
606
590
602
SG&A Expense
367
395
422
435
415
479
EBIT
94
147
121
149
157
104
Unusual Expense
3
3
4
10
-
3
Non Operating Income/Expense
7
25
4
4
22
19
Interest Expense
5
6
6
8
3
2
Pretax Income
94
114
125
129
134
120
Income Tax
33
36
41
40
42
37
Equity in Affiliates
1
1
1
1
1
1
Consolidated Net Income
62
78
85
90
94
84
Net Income
57
74
79
85
88
79
Net Income After Extraordinaries
57
74
79
85
88
79
Net Income Available to Common
57
74
79
85
88
79
EPS (Basic)
16.16
20.71
22.21
23.91
24.82
22.25
Basic Shares Outstanding
4
4
4
4
4
4
EPS (Diluted)
16.16
20.71
22.21
23.91
24.82
22.25
Diluted Shares Outstanding
4
4
4
4
4
4
EBITDA
148
202
179
208
219
171
Other Operating Expense
54
20
22
22
18
18
Non-Operating Interest Income
1
1
1
1
2
1
Minority Interest Expense
5
5
6
5
6
5

About Paul Hartmann

View Profile
Address
Paul-Hartmann-Strasse 12
Heidenheim Baden Wuerttemberg 89522
Germany
Employees -
Website http://www.hartmann.info
Updated 07/08/2019
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following business segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization.